Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Closed
Phase 3
This trial is looking at treatment for acute myeloid leukaemia (AML) and high risk myelodysplastic syndrome (MDS). It is designed mainly for people over 60 years of age who are fit enough to have intensive chemotherapy. But some younger people may be able to take part.
The trial is supported by Cancer Research UK.
Recruitment start: 31 October 2014
Recruitment end: 31 December 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nigel Russell
Cancer Research UK
Cardiff University
Experimental Cancer Medicine Centre (ECMC)
National Cancer Research Institute (NCRI) AML Working Party
This is Cancer Research UK number CRUK/12/043.
Last reviewed: 30 Dec 2022
CRUK internal database number: 10557
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
